BiondVax Pharmaceuticals
1,526
$48.259876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$48.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$2.85 (-5.58%) As of 9:08 AM EDT pre-market
-$2.85 (-5.58%) Pre-Market
Why Robinhood?
You can buy or sell BVXV and other stocks, options, ETFs, and crypto commission-free!
About BVXV
BiondVax Pharmaceuticals Ltd. American Depositary Shares, also called BiondVax Pharmaceuticals, is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. Read More It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel.
Employees
25
Headquarters
Jerusalem, Jerusalem
Founded
2003
Market Cap
315.34M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
241.88K
High Today
$56.60
Low Today
$41.18
Open Price
$52.00
Volume
358.69K
52 Week High
$62.00
52 Week Low
$5.20
Collections
BVXV Earnings
-$0.05
-$0.03
-$0.02
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 26, Pre-Market